Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
Hematology
•
Sickle Cell
•
Pediatric Hematology
•
Benign Hematology
•
Stem Cell Transplantation
What subset of sickle cell disease patients are you offering sickle cell disease gene therapy?
Answer from: at Academic Institution
All patients with Hgb SS and patients with Hgb SC who have had any significant complications, excluding chronic pain.
Sign in or Register to read more
22690
Related Questions
How would you approach secondary stroke prevention in an adult with Hemoglobin SC disease?
How do you counsel sickle cell patients on the use of G-CSF to treat neutropenia from other causes, like malignancy?
How do you approach the work-up for a patient with iron deficiency anemia who is not responding to oral iron therapy?
Can lupus anticoagulant be positive despite a normal aPTT?
How do you manage significant asymptomatic indirect hyperbilirubinemia in patients with hemolytic diseases (SCD, HS, etc.)?
What are your top takeaways in Classical Hematology from ASH 2024?
How do you counsel patients with acute intermittent porphyria when it comes to fasting for religious reasons?
What would you recommend for long term management of extensive dural venous sinus thrombosis (CVST) in young females when the only provoking risk factor is combined OCP?
Can anti-cardiolipin or anti-beta-2 glycoprotein antibodies cause prolonged PTT in the absence of a lupus anticoagulant?
How would you approach post-operative VTE prophylaxis for renal transplant in patients with a prior history of provoked VTE?